WSA
GILD icon

Wealth Science Advisors’s Gilead Sciences GILD Stock Holding History

Wealth Science Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
2,447
-379
-13% -$49.9K 0.14% 80
2026
Q1 		$347K Hold
2,826
– – 0.2% 51
2025
Q4 		$347K Buy
+2,826
New +$343K 0.2% 51

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Wealth Science Advisors's GILD Position: Q2 2026 in Review

Wealth Science Advisors reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $49.9K and leaving 2,447 shares worth $309K. The position accounts for 0.14% of the portfolio, ranked #80.

Wealth Science Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $347K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wealth Science Advisors held 2,447 shares of Gilead Sciences worth $309K as of Q2 2026.
  • Wealth Science Advisors sold 379 Gilead Sciences shares in Q2 2026, an estimated $49.9K.
  • Gilead Sciences made up 0.14% of Wealth Science Advisors's portfolio in Q2 2026, its #80 holding.
  • Wealth Science Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Wealth Science Advisors's Gilead Sciences position peaked at $347K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.